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Supply Chain Risk Factors’ Assessment in the Nigerian Pharmaceutical Industry  Claudius Jamike Agorzie      James Unam Monday      Helen Olubunmi Aderemi Department of Management and Accounting, Obafemi Awolowo University, Ile-Ife, Nigeria  Abstract  The study assessed supply chain risk factors (SCRF) in the Nigerian pharmaceutical industry. Primary data were sourced for this study through a thematic questionnaire served on 300 randomly selected registered pharmacies. By means of bipolar semantic differential scales, respondents were assessed on semantic spaces, the probability of occurrence as well as projected impact of upstream, internal, and downstream supply chain risk factors. Data collected were analysed using probability-impact matrix, and other appropriate descriptive statistics. The results identified 18 risk factors in the Nigerian pharmaceutical supply chain. The risk factors with the greatest probability of occurrence was “excess stocking of products” (probability of 0.583, industry internal sector risk average probability was 0.492), followed by “increase in product prices by suppliers” (0.577, industry upstream sector average was 0.491). Risk factor with the greatest impact assessment was from the downstream; it was “failure to deliver products to customers” (4.453, industry downstream average was 4.112). The next was an upstream factor – “supplier product quality problem” (4.411, industry upstream average was 3.341). “Product expiration on the shelf” had the highest criticality rating (2.318), followed by “increase in product price by suppliers” (2.165), while “poor merchandising” (1.239) had the lowest criticality rating. With these findings, pharmaceutical firms in Nigeria are better equipped to manage and perhaps mitigate risk factors in their supply chain.  Keywords: Supply chain risk management, supply chain, probability, risk-impact matrix   1. Introduction The pharmaceutical industry like any other industry relies on supplies to carry out its functions effectively. For this industry, the supplies are primarily drugs, nutraceuticals, medical materials and all other drug-related items that promote sound health for individuals and animals. Nutraceutical is a portmanteau of the words nutrition and pharmaceutical. The term is applied to products that range from nutrients, dietary supplements and herbal products, specific diets and processed foods such as cereals, soups, and beverages (Kalra, 2003). Hogerzeil (2006) stated that access to medicine, as a human right, is one of the main objectives of healthcare systems. Purchase of medications by customers and health-related institutions serve as the primary source of revenue to pharmaceutical organisations. Therefore, any good pharmaceutical supply chain should provide medicines in the right quantity, with the acceptable quality, to the right place and customers, at the right time and with optimum cost to be consistent with national healthcare systems. In Nigeria presently, the process of delivering genuine medications to the end user is not only long but also in many cases complicated. Such supply chain (SC) processes are prone to risks and uncertainties.  Companies are more than ever, exposed to a diversity of supply chain risks such as product counterfeiting, short product lifecycle, demand and supply volatility, growing regulatory complexity, etc. The pharmaceutical industry is just one of the many industries that have witnessed a remarkable change in their business environment in particular due to increased competitive pressure and the globalization of markets (Zsidisin, 2003; Wagner and Bode, 2009). A consequence of this reality of a relatively unsteady state of the world and an increased vulnerability of supply chain to disruptions is that organisations are compelled to tackle supply chain risks just as they do other business risks (Elkins et al., 2005). It is pertinent to note that any risk affecting the pharmaceutical supply chain, not only can waste healthcare resources but also threaten the nation’s healthcare system and the patients’ life by hindering access to quality medicines (Schneider et al., 2010). In addition, risks involved in the process of satisfying the end user must be understood, monitored and managed so as not to adversely affect the health of the populace. These risks are numerous and have varying levels of impact at different stages of the pharmaceutical supply chain. From the manufacturer to the retailer and down to the terminal consumer, different risks have different impacts on the supply chain efficiency.  In view of the issues raised above, this study made attempt to provide answers to the following questions: What are the risk factors present in the supply chain of the Nigerian Pharmaceutical industry? What are the chances that such risks will occur? In case they do occur, how critical will their impacts be, and which of the risk factors has highest criticality rating; thus, requiring more serious control efforts?  This study reviewed the concepts of supply chain, supply chain risks and probability risk-impact matrix. It identified upstream, internal and downstream risk factors in the Nigerian Pharmaceutical supply chain. In addition, the study determined the probability of occurrence and criticality of the risk factors with a view to prioritizing them to engender their mitigation and/or effective control.  
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2. Literature Review 2.1 Supply Chain (SC) Hanaa (2013:201-210) defined supply chain as “a network of manufacturers and services providers that work together to convert and move goods from the raw materials stage through to the end user”. Those manufacturers and service providers are linked together through physical flow of materials, information and money (Bozarth and Handfield, 2006). According to Stevenson (2012) supply chain is the sequence of organisations – their facilities, functions, and activities – that are involved in producing and delivering a product or service to the final consumer. As can be seen from this definition, the sequence begins with basic suppliers of raw material and terminates with the final consumer of the product or service. The facilities may include warehouses, factories, processing centres, distribution centres, retail outlets and offices. Functions and activities include forecasting, purchasing, inventory management, information management, quality assurance, scheduling, production, distribution, delivery, and customer service. Activities in the supply chain that involve inbound and outbound flow of goods, services, cash and information constitute the logistics.    2.2 Supply Chain Risk (SCR) Risk in the supply chain refers to uncertain or unpredictable events that can negatively affect supply chain functionality or profitability (Claypool et al., 2015). Bavarsad et al. (2014) and Tang (2006) defined  supply  chain risk as the uncertainty  of  the  occurrence  of  an  event  that could  affect  one  (or more)  partner  or  link within the  supply  chain  and  that  could  influence (generally  in a negative sense)  the achievement of company‘s business objectives. In the view of Christopher and Lee (2008) risks in supply chains could be defined as a variation in the distribution of possible supply chain outcomes, their likelihood, and their subjective value. Decision theory underlines the negative consequences of risks and so do researchers in the field of SCRM, who associate SCR with chances of danger, loss, damage or any other undesired consequence (Wagner and Bode, 2008). Among most supply chain risk management (SCRM) scholars, SCR is associated with negativity and undesirable outcome. According to Claypool et al. (2015), some of the SCR include supplier reliability, quality problems, market/demand risks, manufacturing/production problems, capacity risk, strategic exposure risk, demand forecast risk, inventory management/stockout risk, outsourcing risk, etc.  2.3 Supply Chain Risk Management (SCRM) Supply chain risk management can be defined as the process of developing methods and models to identify, assess and mitigate risks in supply chain in order to reduce the impact of the risks (Claypool et al., 2015). According to Ju ttner, Peck and Christopher (2003), SCRM consists of four key management aspects: assessing the risk sources for the SC, defining the SC adverse consequences, identifying risk drivers or factors, and finally mitigating risks for the SC. Tuncel and Alpan (2010) announced that SC risk control involves risk identification, risks assessment, risk management and risk monitoring as the four steps. Managing supply chain, according to Stevenson (2012) involves identifying the risks, assessing their likelihood of occurring as well as potential impact, prioritizing the risks and then developing strategies to manage those them. Abolghasemi et al. (2015) opined that all the proposed process are seeking one goal although they have different implementation stages.  Munyuko (2015) associates SCR with randomness, losses and adverse impact. He is of the opinion that most organisations do not have risk management programs where they identify the potential risk within their supply chain and come up with contingency plans to mitigate them.  Vikulov and Butrin (2014) propose a classification that allows identifying risks in specific links of supply chains. They identified risk categories at major supply chain link and business processes thus: (a) suppliers (Delivery, schedule, Prices, Non–delivery/Short-delivery, Poor-quality), (b) transportation (Damage of goods in transit and loss of goods in transit), (c) warehousing (damage of good during storage, changes in taxes and other costs of warehousing), (d) production (quality problems, overproduction, disruptions due to equipment failure, and disruptions due to procurement issues), and (e) marketing (volatile demand, wrong promotion strategy, and failure of networking sales). The items in the brackets are the compositions of the risk factor which they highlighted. According to Behnezhad et al. (2013) and Abolghasemi et al. (2015) the ultimate goal of supply chain risk management process is to protect the integrity of organisation against the unfortunate events and their consequences in order to gain maximum power and ability to make as much as profit as possible. The lack of effective risk management has caused many organisations to suffer untold loss. For example, Apple and Ericsson suffered over 400 and 300 million euros losses respectively due to poor risk management (Norman and Jansson, 2004).  According to Abolghasemi et al. (2015), Supply Chain Council members have reported that less than half of enterprises have established metrics and procedures for assessing and managing supply [chain] risk. In addition, organisations lack sufficient market intelligence, process, and information systems to effectively predict and mitigate supply chain risks he concluded. This expression agrees with the opinion of Christopher et al. (2011: 68) who said, “Most companies do not have a structured management and mitigation system covering 
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supply chain risk”. Hendrick, Singhai and Zhang (2009) see this as one of the reasons why desired performance is not achieved in supply chains.   2.4 Probability-Risk Matrix Risk components usually manifest themselves in two forms – Hazards or Harms. Hazards represent the potential source of a harmful event or the cause. Harms are the resulting damages to products, persons, systems, or the environment (the effect). Risk is essentially cause and effect on a defined scale. Organisations, when trying to quantify these two parameters often consider two metrics namely: severity (impact) and frequency (likelihood or probability) of occurrence (Lozier, 2011). With these metrics, a number of numeric, qualitative (verbal) or both scales can be developed to measure hazard and harm. The numeric scales (1-improbable, 2-seldom, 3-occasional, 4-likely, 5-frequent), and qualitative/verbal (negligible, minor, moderate, critical, catastrophic) are examples of scales that could be developed. When these are graphed with frequency placed on the vertical (ordinate) axis, and severity on the horizontal (abscissa) axis, the result will be a matrix that highlights the risk zones using the product of the numbers on the axes. Dani (2009), and Ouabouch and Amri (2013) suggested a formula that calculates the variable - criticality level (Ci) of a risk factor, based on the product of averages of the probability (Pi) and impact (Mi)    ∗  ……………………. (1) When a risk matrix is developed, it has to be vetted by putting it through the organisation’s past historical experiences to see the level of correlation between the risk level by the matrix and reality. This  retrospective test or real world honing will help in determining the level of tweaking or fine-tuning the matrix will require before it becomes a reliable bases for decision-making on risk.     3. Methodology Cross sectional survey design was adopted for the study. This generated primary data through the use of a thematic questionnaire. The study covered the downstream sector of the pharmaceutical industry particularly the retail pharmacies registered by the Pharmacy Council of Nigeria. The sample size for the study was 300 randomly selected retail pharmacies in the country. Convenience sampling was used to select the respondents from staff in the category of Directors/Pharmacists, Manager/Pharmacists, Superintendent/Pharmacists, Pharmacists, and Doctors who are employee of the firms being studied.  As advocated by previous studies in SCRM, in this study SCR will be grouped into three:  Upstream, Internal and Downstream supply chain risks (Ouabouch and Amri, 2013; Vikulov and Butrin, 2014). Upstream supply chain risks factors (SCRF) were: failure of suppliers to deliver products, untimely delivery of products by suppliers, increase in product prices from suppliers, supplier products quality problems.  Internal SCRF were: product expiration on shelves, inventory shortage of new items, inventory mismanagement, poor product knowledge, excessive stocking, low stocking, poor merchandizing, poor customer service by employees, outage of IT/computer systems, and accidental product damage. Downstream SCRF were: unexpected consumer demand fluctuations, decline in market prices, untimely delivery of products to customers, and failure to deliver product to customers. Using bipolar semantic differential scales, respondents made an assessment on a semantic space (with 0.1 - 1.0) the probability of occurrence and projected impacts of the above risks factors. The bipolar adjectives used for the probability assessments were from never to always, and for impact of the risk no consequence to very serious consequence.  The severity or criticality of the risk factor is calculated using equation (1) above: Criticality of risk factor () = Probability of risk factor (	) x Impact of risk factor (	) Data were processed using Microsoft Excel and appropriate descriptive statistics.  3. Results and Discussion of Findings 3.1 Response Rate, Respondents’ Characteristics and Classification  Three hundred (300) copies of the instrument were distributed but two hundred and eighty (287) properly completed copies were retrieved. This yielded a response rate of 95.7%.  From Table 1, it is evident that all the respondents are pharmacists and over 97% hold a minimum of first degree (B. Sc.) in the discipline. Over 42% has worked for a minimum of one year in the supply chain of the Nigerian pharmaceutical industry and over 49% has at least six months working experience in the chain. The respondents are knowledgeable persons in the industry.   
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Table 1. Respondents’ Characteristics and Classification (N = 287) Educational Qualification B. Sc. 144(50.17%) M. Sc. 137(47.74%) Ph. D 2(0.70%) Fellowship 4(1.39% ) Total 287 (100%) Professional  Status Pharmacist 217 (75.61%) Superintendent/ Pharmacist 33(11.50% ) Manager/ Pharmacist 13(4.53%) Director/ Pharmacist 22(7.67%) Doctor 2(0.70%) Work Experience No Response 4(1.39%) Less than 6 months 21(7.32%) 6 to 12 months 141(49.13%) 1 to 3 years 81(28.22%) 4 years or more 40(13.94%)   3.2 Supply Chain Risk Factors and their Probabilities  Table 2 presents eighteen supply chain risk factors present in the supply chain of the Nigerian pharmaceutical industry along with their probability of occurrence as assessed by the respondents. Each of the Upstream and Downstream sectors of the chain has four risk factors while the internal sector has ten risk factors. Upstream Risk Factors (suppliers failure to have or deliver products, untimely delivery of products by suppliers, increase in product prices by suppliers, supplier products' quality problems), Internal Risk Factors (product expiration on shelves, inventory mismanagement, poor product knowledge by branch staff, excess stocking, low stocking, inventory shortage of new items, poor merchandising (product arrangement), poor customer service by branch staff, IT/computer related problems, accidental product damage), and Downstream Risk Factors (unexpected consumer demand fluctuations, decline in market prices (after purchasing from suppliers), untimely delivery of products to customers, failure to deliver product to customers)  The most probable risk factor in the upstream, internal and downstream sectors are “increase in product prices by suppliers” (with probability assessment of 0.5763), “excess stocking” (0.5833), and “unexpected consumer demand fluctuations” (0.4909) respectively. The most probable risk factor in the chain is “excess stocking” which has a probability rating of 58.33%. On the average, the sector in the supply chain with most probable risk factor is the internal sector with average probability assessment of 49.19%. This value suggests that on the average, the chance of occurrence and non-occurrence of those ten risk factors in the internal sector of the chain is approximately equally likely.   3.3 Impact of Risk Factors Table 3 reveals the level of impact each risk factor can create according to the respondents’   assessments. “Failure to deliver product to customers” – a downstream sector risk factor - created the greatest impact (with assessed value of 4.453 and a rating of “serious consequence”) in the chain. The downstream sector had the greatest average impact (assessed to be 4.3728). The risk factor with the second greatest impact is “supplier product quality problems” – an upstream risk factor – with an impact assessment of 4.4111 and a rating of “serious consequence”. Each of the four risk factors in the downstream sector of the chain has impact rating of “serious consequence”.  3.4 Criticality of Risk Factors Table 4 shows the probability, impact and criticality values of the supply chain risk factors. “Product expiration on the shelf” - an internal risk factor - has the highest criticality value of 2.318 and it is followed by “increase in product prices by suppliers” with a criticality value 2.163 (see Figure 1). “Poor customer service by firm staff” comes third with criticality value of 2.204.  Table 5 presents the eighteen risk factors in the Nigerian pharmaceutical supply chain in a descending order of criticality. This table can be useful to the industry in prioritising risk management and control. “Suppliers’ failure to deliver product to customers” has the highest impact (see Table 3) but the lowest criticality of 1.355 (Table 5).  
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 Figure 1. Criticality of Nigerian Pharmaceutical Industry Supply Chain Risk Factors  3.5 Prioritizing the SCRFs Table 5 presents the risk factors in descending order of criticality or severity. Each of the first three factors on the table has a criticality value above two (2). The factors are: product expiration on shelves (2.318), increase in product prices by suppliers (2.163), and poor customer service by branch staff (2.024). From Table 4, one observes that these factors also have high probability of occurrence and high impact as well. These factors are IR1, UP3 and IR8 (IR refers to Internal risk, UP is for upstream risk), they are in the red region of the probability risk matrix – a clear indication that they require careful management and control. The other factors may similarly be investigated.  The risk matrix – Figure 2 - shows the overall picture of the supply chain risk assessment factors in the Nigerian Pharmaceutical  supply chain with the probability increasing from left to right and moving towards the upper right corner (red zone), indicating the level of criticality of the supply chain risk factors. As shown in Figure 2, “failure to deliver product” (DR4) can be considered as the most probable risk factors, while “product expiration on shelf” (IR1) and “increase in product prices by suppliers” (UP3) can be considered to have the greatest impact. However, “supplier products quality problems” (UP4), “untimely delivery of product to customers” (DR3) and “suppliers’ failure to deliver product to customers” (DR4) have higher probability of occurrence, but the impact tends to be moderate. The highest probability was observed in “failure to deliver product” (DR4), while the internal risk factors had the least criticalities. Factors that are located in top right corner or the red area of the matrix are those with very high criticality (high probability and high impact) such as IR1and UP3. A number of the factors are in this region or very close to it – a clear indication of the severity of risk factors in the Nigerian Pharmaceutical Supply Chain.  
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Table 5. SCRFs in Descending Order of Criticality Risk Factor   Criticality  Product expiration on shelves 2.318 Increase in product prices by suppliers 2.163 Poor customer service by branch staff 2.024 Decline in market prices (after purchasing from suppliers) 1.981 Untimely delivery of products to customers 1.946 Inventory shortage of new items 1.863 Supplier products' quality problems  1.826 Unexpected consumer demand fluctuations 1.811 Untimely delivery of products by suppliers 1.780 Excess stocking 1.740 IT/Computer related problems 1.653 Poor merchandising (product arrangement) 1.636 Low stocking 1.553 Poor product knowledge by branch staff 1.540 Failure to deliver product to customers 1.488 Accidental product damage 1.484 Inventory mismanagement 1.470  Failure to deliver product 1.355 Nigerian pharmaceutical industry sources her pharmaceuticals through importation. Thus the availability of products from importers can be a source of risk. However, the findings reveal a relatively low criticality (1.355) for availability of products from suppliers. Product expiration on shelves (2.318) is the most grave. This severity may originate from three major factors - consumer demand fluctuations, inventory mismanagement and poor product knowledge.   Another risk factor that displayed a high criticality is the increase in product prices by suppliers (2.163).  This did not come as a surprise considering the fact that majority of drug products are imported and the naira exchange rate has experienced a high level of volatility in recent years. Figure 2 above shows graphically that the SCRFs have the tendency to severely affect activities in the Nigerian Pharmaceutical Industry.  4. Conclusion The study identified supply chain risk factors (SCRF) present in the Nigerian pharmaceutical supply chain (NPSC), determined the probability of occurrence of those risks factors in the supply chain (SC), examined the level of impact of the risk factors; and measured the criticality (severity) of those SCRF with a view to prioritizing them. Eighteen risk factors or risk drivers were identified to be present in the Nigerian Pharmaceutical Industry Supply Chain. This study revealed that the risk factors with the greatest probability of occurrence were excess stocking of products, and increase in product prices by suppliers; while risk factors with the greatest impact assessment were failure to deliver products to customers, and supplier product quality problem. Product expiration on the shelf had the highest criticality rating, followed by increase in product price by suppliers, while poor merchandising had the lowest criticality rating. With these findings, pharmaceutical firms in Nigeria are better equipped to manage and perhaps mitigate risk factors in their supply chain. In their operations, firms in the pharmaceutical industry are exposed to risks that are very critical. The study underscores the need for pharmaceutical firms in Nigeria to promptly develop risk management programs if this is not already in existence. This step engenders effective management and/or mitigation of supply chain risks.      
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  0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 Suppliers failure to have or deliver product 63 45 40 17 44 16 21 16 18 7 0.406 Untimely delivery of products by suppliers 19 15 26 22 79 27 40 26 22 11 0.546 Increase in product prices by suppliers 11 20 18 20 80 25 45 28 20 20 0.576 Supplier products' quality problems  40 47 55 18 52 18 25 18 10 4 0.414 Upstream Risk Factors  Average Probability = 0.486 Product expiration on shelves 26 26 30 26 17 21 29 51 51 10 0.576 Inventory mismanagement 44 33 30 31 25 43 10 50 19 2 0.477 Poor product knowledge by branch staff 50 35 32 60 22 50 6 24 5 3 0.409 Excess stocking 30 21 36 32 17 19 11 8 104 9 0.583 Low stocking 44 33 30 31 25 43 10 50 19 2 0.477 Inventory shortage of new items 33 8 44 38 22 24 8 12 95 3 0.566 Poor merchandising (product arrangement) 60 30 41 23 52 55 8 11 4 3 0.396 Poor customer service by branch staff 35 32 48 37 18 12 4 90 9 2 0.489 IT/Computer related problems 55 18 36 39 23 57 12 10 30 7 0.459 Accidental product damage 35 32 48 37 18 12 4 90 9 2 0.489                                                    Internal Risk Factors   Average Probability = 0.492 Unexpected consumer demand fluctuations 11 8 28 126 32 22 18 13 18 11 0.491 Decline in market prices (after purchasing from suppliers) 48 22 38 19 22 25 88 12 7 6 0.480 Untimely delivery of products to customers 62 40 42 22 77 14 10 10 5 5 0.373 Failure to deliver product to customers 89 57 35 26 21 14 16 17 10 2 0.334 Downstream Risk Factors   Average Probability = 0.419 Key:   F = Frequency, p = Probability value  
Probability y  
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Table 3. Downstream, Internal and Upstream Risk Factor Impacts (N = 287)  Risk Factors Impact(W)  and Frequency(F) Impact Value  Criticality NC LC CC SC VSC Rating (P x I) 
Upstream
 Risk Factors Suppliers failure to have or deliver product 10 24 154 56 43 3.342 CC 1.355 Untimely delivery of products by suppliers 5 17 194 41 30 3.258 CC 1.78 Increase in product prices by suppliers 4 10 62 188 23 3.753 SC 2.163 Supplier products' quality problems  7 9 27 60 184 4.411 SC 1.826 Upstream Risk Factors Average Impact = 3.691  
Internal 
Risk Fac
tors Product expiration on shelves 9 7 31 161 79 4.024 SC 2.318 Inventory mismanagement 14 24 188 46 15 3.084 CC 1.47 Poor product knowledge by branch staff 15 15 51 174 32 3.673 SC 1.54 Excess stocking 18 120 32 83 34 2.983 CC 1.74 Low stocking 12 26 149 76 24 3.258 CC 1.553 Inventory shortage of new items 11 19 168 48 40 3.293 CC 1.863 Poor merchandising (product arrangement) 6 16 35 106 124 4.136 SC 1.636 Poor customer service by branch staff 9 13 36 99 130 4.143 SC 2.024 IT/Computer related problems 15 18 54 178 22 3.606 SC 1.653 Accidental product damage 15 35 178 42 17 3.038 CC 1.484                                                 Internal Risk Factors Average Impact = 3.5234  
Downstre
am 
Risk Fac
tors Unexpected consumer demand fluctuations 22 55 20 83 107 3.690 SC 1.811 Decline in market prices (after purchasing from suppliers)  10 16 37 88 136 4.129 SC 1.981 Untimely delivery of products to customers 10 22 24 83 148 4.174 SC 1.946 Failure to deliver product to customers 9 8 35 27 208 4.453 SC 1.488 Downstream Risk Factors Average Impact = 4.112  Key: NC = No Consequence; LC = Little Consequence; CC = Considerable Consequence; SC = Serious Consequence; VSC = Very Serious Consequence Code: NC = 1; LC = 2; CC = 3; SC = 4; VSC = 5  Table 4. SCRF Probability, Impact and Criticality Values  Risk Factors Probability(p) Impact(I) Criticality (= p x I ) 
Upstream
 
Risk Factor   
Suppliers failure to have or deliver product 0.406 3.342 1.355 Untimely delivery of products by suppliers 0.546 3.258 1.780 Increase in product prices by suppliers 0.576 3.753 2.163 Supplier products' quality problems 0.414 4.411 1.826 
Internal 
Risk Fac
tors Product expiration on shelves 0.576 4.024 2.318 Inventory mismanagement 0.477 3.084 1.470 Poor product knowledge by branch staff 0.409 3.673 1.504 Excess stocking 0.583 2.983 1.740 Low stocking 0.477 3.258 1.553 Inventory shortage of new items 0.566 3.293 1.863 Poor merchandising (product arrangement) 0.396 4.136 1.636 Poor customer service by branch staff 0.489 4.143 2.024 IT/Computer related problems 0.459 3.606 1.653 Accidental product damage 0.489 3.038 1.484 
Downstre
am 
Risk Fac
tor Unexpected consumer demand fluctuations 0.491 3.690 1.811 Decline in market prices (after purchasing from suppliers) 0.480 4.129 1.981 Untimely delivery of products to customers 0.373 4.174 1.946 Failure to deliver product to customers 0.334 4.453 1.488 Average Values 0.474 3.750 1.755  Criticality = Probability (p) x Impact (I)    
